CellNovo

About:

CellNova is a medical technology company that specializes in diabetes.

Twitter/X: Cellnovo

Top Investors: European Investment Bank, Andera Partners, Omnes Capital, Forbion Capital Partners, Kreos Capital

Description:

CellNova is a medical device company. They specialized in diabetes. They develop and market the systems they connect diabetes management system through mobile. Their automatic transmission of data allows the patient's condition to monitor.

Total Funding Amount:

$103M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Paris, Ile-de-France, France

Founded Date:

2002-01-01

Contact Email:

info(AT)cellnovo.com

Founders:

Joseph Cefai, Julian Shapley

Number of Employees:

51-100

Last Funding Date:

2017-07-10

IPO Status:

Public

Industries: